8 hours ago Richmond University Medical Center (RUMC) provides health services to Staten Island, NY, including anesthesia, behavioral health, mental health, substance abuse ... >> Go To The Portal
Richmond University Medical Center (RUMC) provides health services to Staten Island, NY, including anesthesia, behavioral health, mental health, substance abuse ...
Dr. Melvin David Koplow, DO. Pediatrician (Kids / Children Specialist) 43 Years of Experience. Call (718) 948-6162. Accepting patients. About Insurance Other Specialists. About Dr. Melvin David Koplow, DO. Practice Location. Dr. Melvin Koplow, DO. 531 Huguenot Ave. Staten Island, NY 10312 (718) 948-6162.
Melvin D. Koplow, DO earned a degree of a Doctor of Osteopathic Medicine. Licenses and Affiliations. Melvin D. Koplow, DO has been registered with the National Provider Identifier database since July 15, 2006, and his NPI number is 1437175023. Book an Appointment. To schedule an appointment with Dr. Melvin D. Koplow, please call (718) 948-6162.
Background: Patient-centered care is respectful of and responsive to individual patient preferences, needs, and values. To provide patient-centered care, clinicians need to know and incorporate patients' context into their communication and care with patients. Patient contextual data (PCD) encompass social determinants of health and patients' needs, values, goals, and preferences relevant to their care. PCD can be challenging to collect as a routine component of the time-limited primary care visit. Objective: This study aims to determine if patient-provider communication and patient activation are different for patient users and patient nonusers of an electronic health record (EHR)-integrated PCD tool and assess if the impact of using PCD on patient-provider communication and patient activation differs for Black and White patients. Methods: We describe a randomized controlled trial of a prospective cohort of non-Hispanic White and Black patients who receive primary care services at a midwestern academic health care system in the United States. We will evaluate whether providing PCD through a consumer informatics tool enhances patient-provider communication, as measured by the Communication Assessment Tool, and we will evaluate patient activation, as measured by the Patient Activation Measure for PCD tool users and nonusers. Furthermore, owing to racial disparities in care and communication, we seek to determine if the adoption and use of the tool might narrow the differences between patient groups. Results: The trial was funded in November 2017 and received local ethics review approval in February 2019. The study began recruitment in April 2019 and enrollment concluded in October 2019 with 301 participants. The analysis was completed in May 2020, and trial results are expected to be published in winter 2020. Conclusions: Recently, there has been increased attention to the role of health information technology tools to enable patients to collaborate with providers through the sharing of PCD. The adoption of such tools may overcome the barriers of current EHRs by directly engaging patients to submit their contextual data. Effectively, these tools would support the EHR in providing a more holistic understanding of the patient. Research further supports that individuals who have robust digital engagement using consumer informatics tools have higher participation in treatment follow-up and self-care across populations. Therefore, it is critical to investigate interventions that elicit and share patients' social risks and care preferences with the health care team as a mechanism to improve individualized care and reduce the gap in health outcomes. Trial registration: ClinicalTrials.gov NCT03766841; https://clinicaltrials.gov/ct2/show/NCT03766841. International registered report identifier (irrid): RR1-10.2196/20309.
However, telehealth will continue to be an integral part of urology after the pandemic and our field should embrace telehealth and develop strategies to overcome associated challenges.
Background: Electronic patient portal (EPP) use has been associated with a number of benefits in the internal medicine setting. Few studies have examined the disparities in and the benefits of EPP utilization among surgical patients. The purposes of this study were to examine factors associated with EPP use among patients undergoing an orthopaedic surgical procedure and to determine if EPP use is associated with improved outcomes or satisfaction after orthopaedic surgical procedures. Methods: We queried all patients undergoing an orthopaedic surgical procedure from May 2015 to December 2018 at 2 academic medical centers in an integrated hospital system. Patient demographic characteristics, operative characteristics, satisfaction scores, and patient-reported outcome measures (PROMs) were collected. Multivariable logistic regression was used to identify disparities in EPP use. Adjusted logistic and linear regressions were then used to assess the association between EPP use and the various outcome metrics while controlling for confounders identified in the previous analysis. Results: Numerous demographic factors were independently associated with EPP use among patients undergoing an orthopaedic surgical procedure, including English speakers compared with non-English speakers (odds ratio [OR], 2.37 [95% confidence interval (CI), 2.01 to 2.79]); African-American or black race (OR, 0.42 [95% CI, 0.36 to 0.48]) and Hispanic race (OR, 0.52 [95% CI, 0.44 to 0.61]) compared with white race; college education compared with high school education (OR, 2.30 [95% CI, 2.12 to 2.49]); and a surgical procedure for orthopaedic trauma compared with that for the hand or upper extremity (OR, 0.51 [95% CI, 0.45 to 0.58]) (p < 0.001 for all), among others. EPP use was independently associated with the increased likelihood of completing a PROM (OR, 1.57 [95% CI, 1.45 to 1.7]) and a satisfaction survey (OR, 2.38 [95% CI, 2.17 to 2.61]) and improved overall patient satisfaction (mean difference, 2.61 points [95% CI, 1.79 to 3.43 points]) (p < 0.001 for all). Finally, EPP use was independently associated with lower mean no-show rates (6.8% [95% CI, 6.4% to 7.2%] compared with 9.3% [95% CI, 8.9% to 9.7%]). The lower no-show rate for EPP users corresponded to an estimated $218,225 in savings for our institution within the first postoperative year. Conclusions: This study identified significant disparities in EPP use among patients undergoing an orthopaedic surgical procedure. Given that EPP use was independently associated with lower no-show rates and improved patient satisfaction among patients undergoing an orthopaedic procedure, efforts to reduce these disparities are warranted. Clinical Relevance: EPPs are increasingly being used by health-care systems to improve communication between providers and patients; however, providers should be aware of and strive to eliminate disparities in EPP utilization among orthopaedic patients. Within orthopaedic surgery, EPPs are associated with a number of benefits, including lower no-show rates and increased patient satisfaction.
The growing field of patient ergonomics is built on an understanding that patients and their social network members increasingly play a key role in managing their health and healthcare across a wide range of settings including the home, workplace, and community. Over the last several years, we have traced, explored, and debated emerging research in this area, including the theories, methods, and strategies for implementation that are needed to support this new area of human factors and ergonomics. In this current panel, we begin a new dialogue in this space, one that is inspired not only by our previous discussions but also by recent conversations in our community about the need for human factors and ergonomics to consider issues of inclusivity, diversity, and social justice. To that end, each of our five panelists will present the patient ergonomics research they are conducting within a historically marginalized community or population and highlight lessons learned from their experiences. This presentation of work spanning considerations of gender, age, race, geographic setting, educational background, and disability will serve as a foundation for a wider discussion with the audience about how patient ergonomics as a field can prioritize and support this type of work.
Telepsychiatry refers to the use of technology to support the remote provision of psychiatric services. Discussions of this technology have often focussed on the use of video conferencing in place of in-person visits and how such care is found to be non-inferior to traditional care. New developments in the fields of remote-sensing and digital phenotyping have the potential to overcome the limitations inherent in remote visits as well as the limitations of current outpatient care models more generally. Such technologies may enable the collection of more relevant, objective clinical data which could lead to improved care quality and transformed care delivery models. The development and implementation of these new technologies raise important ethical questions.